Setting 
My Cart

Ordered before 17:30, shipped today - Support: (012) 800 456 789

Track Your Order

Toggle Nav
mobile icon
Close
  • Menu
  • Setting
  • Home
  • Search results for: 'k 115 free base'

Search results for: 'k 115 free base'

Items 1-10 of 44

Page
per page
  1. BMS-345541(free base)
    B4655 BMS-345541(free base)
    Summary: IKK-1/IKK-2 inhibitor,potent and selective
      insoluble in H2O; ≥70 mg/mL
  2. MG-115
    A2612 MG-115
     1 Citation
    Target: Proteasome
    Summary: Potent reversible proteasome inhibitor
      ≥23.08 mg/mL
  3. K-Ras(G12C) inhibitor 6
    B3694 K-Ras(G12C) inhibitor 6
    Target: KRAS G12C
    Summary: K-Ras (G12C) inhibitor
      insoluble in H2O; insoluble in EtOH; ≥20.25 mg/mL
  4. Ionomycin free acid
    B6947 Ionomycin free acid
    Target: Calcium ionophores
    Summary: calcium ionophore
      Soluble in ethanol or DMSO
  5. Tozadenant
    A3885 Tozadenant
    Target: Adenosine A2A Receptors
    Summary: Adenosine 2a receptor antagonist,novel and selective
      insoluble in EtOH; insoluble in H2O; ≥20.35 mg/mL
  6. NVP-BSK805 2HCl
    A4148 NVP-BSK805 2HCl
    Target: JAK
    Summary: JAK2 inhibitor
      ≥30.8 mg/mL
  7. CCT128930 HCl
    A8617 CCT128930 HCl
    Target: Akt
    Summary: AKT inhibitor
      insoluble in H2O; ≥17.1 mg/mL
  8. Rolapitant HCl
    B5910 Rolapitant HCl
    Target: NK1 Receptors
    Summary: Orally active neurokinin NK1 receptor antagonist.
  9. PMX 205 Trifluoroacetate
    B7787 PMX 205 Trifluoroacetate
    Target: C5a receptors
    Summary: C5a receptor peptide antagonist
      ≥97.8 mg/mL
  10. THZ1 Hydrochloride
    B4736 THZ1 Hydrochloride
    Target: Cyclin-Dependent Kinases
    Summary: CDK7 inhibitor
      ≥30.13 mg/mL

Items 1-10 of 44

Page
per page
Shop By
Now Shopping by
  1. Specificity Selective Remove This Item
Clear All
Shopping Options
Category
  1. Signaling Pathways 43item
Reversibility
  1. Reversible 1 item
  2. Irreversible 2item
Target
  1. Cyclin-Dependent Kinases 1 item
  2. Adenosine A2A Receptors 1 item
  3. Proteasome 1 item
  4. Cathepsins 2item
  5. Histone Deacetylases (HDACs) 1 item
  6. Akt 1 item
  7. PI3K 2item
  8. MDM2 1 item
  9. AP-1 1 item
  10. MMP 1 item
  11. PLK 1 item
  12. Voltage-gated Sodium (NaV) Channels 1 item
  13. Deubiquitinating enzymes (DUBs) 1 item
  14. STAT 1 item
  15. Estrogen and Related Receptors 1 item
  16. ROCK 1 item
  17. JAK 1 item
  18. DNA-PK 1 item
  19. HSP90 1 item
  20. CFTR 1 item
  21. Cytochrome P450 (CYP450) 1 item
  22. ErbB 1 item
  23. c-MET 1 item
  24. Calpains 1 item
  25. 5-HT2 Receptors 2item
  26. Calcium ionophores 1 item
  27. Sphingosine kinases (SphKs) 1 item
  28. KRAS G12C 1 item
  29. NK1 Receptors 1 item
  30. D2 Receptors 1 item
  31. Free Fatty Acid Receptors 2item
  32. C5a receptors 1 item
  33. Na /K ATPases 2item
  34. Na /K /Cl- Symporters (NKCCs) 1 item
  35. GABAA Receptors 1 item
  36. 15-lipoxygenases 1 item
  37. O6-methylguanine-DNA-methyl-transferase (MGMT) 1 item
  38. Papains 1 item
  39. BACE 1 item
  40. DPP-4 1 item
  41. FPTase 1 item
  42. Ftase 1 item
Reported Experiments
  1. Animal Experiments 38item
  2. Cell Experiments 28item
Related Disease
  1. Breast Cancer 2item
  2. Cancer 18item
  3. Chronic Lymphocytic Leukemia 1 item
  4. Colon Cancer 1 item
  5. Colorectal Cancer 3item
  6. Diabetes 1 item
  7. Glioblastoma 1 item
  8. Glioma 1 item
  9. Heart Failure 1 item
  10. Hepatocellular Carcinoma 2item
  11. Inflammatory Diseases 1 item
  12. Leukemia 1 item
  13. Lung Cancer 1 item
  14. Melanoma 2item
  15. Multiple Myeloma 2item
  16. Non-small Cell Lung Cancer 2item
  17. Osteoporosis 2item
  18. Ovarian Cancer 1 item
  19. Prostate Cancer 4item
  20. Renal Cell Carcinoma 1 item
  21. Type 2 Diabetes 1 item